Document Page: First | Prev | Next | All | Image | This Release | Search
File: aabod_01.txt
SUBJECT: RE-IMMUNIZATION OF MAC C-141 AND C-5 AIRCREW WITH IMMUNE SERUM GLOBULIN
UNCLASSIFIED
PENTAGON
OPERATIONS DIRECTORATE
PRIORITY ZYUW RHCUCAT5002 2981640
P 251640Z OCT 90
FM HQ MAC CRISIS ACTION TEAM SCOTT AFB IL
TO RHIUFAA/USCENTAF FWD//SG//
INFO RUDOHAA/CENTCOM//SG//
RHDIAAA/HQ TAC LANGLEY AFB VA//SG//
RHCUAAA/USTRANSCOM CAT SCOTT AFB IL//SG//
RUEAHQA/HQ USAF WASHINGTON DC//SGHR/MRC//
UNCLAS
DESERT SHIELD//
MSGID/RI//
NARR/SUBJECT: RE-IMMUNIZATION OF MAC C-141 AND C-5 AIRCREW WITH
IMMUNE SERUM GLOBULIN//
1. ALL MAC PERSONNEL DEPLOYED TO CENTCOM AOR ARE IMMUNIZED WITH 2CC
IMMUNE SERUM GLOBULIN (ISG) WHICH SHOULD PROVIDE PROTECTION AGAINST
HEPATITIS ''A'' FOR APPROXIMATELY 3 MONTHS. BY MID NOVEMBER, A NUMBER
OF MAC PERSONNEL STATIONED IN THE AOR WILL NEED RE-IMMUNIZATION.
WILL THESE PERSONNEL BE RE-IMMUNIZED BY SUPPORTING MEDICAL PERSONNEL?
2. SECOND SITUATION. MAC C-141 AND C-5 AIRCREWS (PILOTS, NAVIGATORS,
FLIGHT ENGINEERS AND LOADMASTERS) CURRENTLY DO NOT REMAIN IN THE AOR
EXCEPT FOR A 3-4 HOUR AIRCRAFT TURNAROUND. DUE TO SHORT GROUND TIME,
THE RISK OF EXPOSURE TO HEPATITIS IS LOW. CURRENTLY, THERE ARE
APPROXIMATELY 15,000 ACTIVE DUTY AND RESERVE FORCES C-141 AND C-5
AIRCREW MEMBERS. WE REQUEST THE CENTCOM REQUIREMENT FOR ISG
RE-IMMUNIZATION OF MAC C-141 AND C-5 AIRCREW MEMBERS WHO REMAIN IN
THE AOR FOR LESS THAN 6 HOURS BE WAIVED. IF OVERT HOSTILITIES BEGIN,
MAC WILL IMMEDIATELY REVERT TO RE-IMMUNIZATION OF ALL AIRCREW
MEMBERS. ALL AIRCREW MEMBERS WILL CONTINUE TO RECEIVE INITIAL ISG
IMMUNIZATION.
3. PLEASE PROVIDE COORDINATED CENTAF AND CENTCOM SG RESPONSE.
4. [O(2)]
CLOSTEXT//
BT
MESSAGE PREPARATION HINT
Y WHEN TYPING A MESSAGE ON BOND PAPER, USE A BLANK DD FORM
173 as a GUIDE TO ENSURE IT HAS PROPER MARGINS AND FORMAT.
DISTRIBUTION 4
ACTION (U,F)
I INFO SGHR/MRC(2L CSS VIA XOXO() FILE CY()
,: MCN=90298/29895 TOR9029B/1648Z TAD-90298/1649Z CDSN;MAD552
*AIR FORCE MESSAGE* PAGE 1 OF 1
251640Z OCT 90
Document Page: First | Prev | Next | All | Image | This Release | Search